Genetic control of T and B lymphocyte activation in nonobese diabetic mice

Journal of Immunology

Volumn 167, Issue 12, 2001, Pages 7169-7179

  Chiu, P P L ^a   Jevnikar, A M ^a   Danska, J S ^a  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL INFILTRATION; CELL SURFACE; CONTROLLED STUDY; FEMALE; GENE CONTROL; GENE DELETION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC LINKAGE; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MALE; MOUSE; NONHUMAN; PANCREAS ISLET CELL; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THYMOCYTE;

EID: 0035892990     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.12.7169     Document Type: Article

References (99)

1. Expression of homing and adhesion molecules in infiltrated islets of Langerhans and salivary glands of nonobese diabetic mice
2. The role of B cells in lprllpr-induced autoimmunity
3. Organ-specific disease provoked by systemic autoreactivity
4. Increased numbers of in vivo activated T cells in patients with recent onset insulin-dependent diabetes mellitus
5. Correlation of clonal T cell expansion with disease activity in systemic lupus erythematosus
6. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-Iprllpr mice
7. Increased CD69 and human leukocyte antigen-DR expression on T lymphocytes in insulin-dependent diabetes mellitus of long standing
8. + T cells expressing early activation antigen CD69 in murine lupus: Possible abnormal regulatory role for cytokine imbalance
9. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus
10. Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of Th 2-type cytokines
11. The fate of activated T cells migrating through the body: Rescue from apoptosis in the tissue of origin
12. + T cells to protein antigens in vivo
13. Induction of autoreactive B cells allows priming of autoreactive T cells
14. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus
15. Genetic dissection of SLE pathogenesis: Adoptive transfer of Slel mediates the loss of tolerance by bone marrow-derived B cells
16. Genetic dissection of systemic lupus erythematosus pathogenesis: sle2 on murine chromosome 4 leads to B cell hyperactivity
17. Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis
18. Diabetes mellitus
19. Persistent T cell activation predicts diabetes in unaffected identical co-twins of type I diabetics
20. Cytokine secretion patterns in twins discordant for type I diabetes
21. Genetic dissection of autoimmune type I diabetes in the BB rat
22. Breeding of a nonobese diabetic strain of mice
23. Type I diabetes and the control of dexamethasone-induced apoptosis in mice maps to the same region on chromosome 6
24. Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the ldd5 diabetes susceptibility region
25. Breaking self-tolerance in nonobese diabetic mice
26. Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response
27. Peri-islet infiltrates of young nonobese diabetic mice display restricted TCR β-chain diversity
28. + T cells with Mtv-3
29. A role for clonal inactivation in T cell tolerance to Mls-1
30. The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD
31. nod mice
32. B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice
33. Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in nonobese diabetic mice
34. Development of insulitis and diabetes in B cell-deficient NOD mice
35. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice
36. B lymphocytes are critical APCs for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice
37. Impaired CD4 T cell activation due to reliance upon B cell-mediated costimulation in nonobese diabetic (NOD) mice
38. a-reactive T cells by B cells but not by dendritic cells or macrophages
39. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens
40. Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus
41. + T cells
42. Hypogammaglobulinaemia occurs in Fas-deficient MRL-lpr mice following deletion of MHC class II molecules
43. - thymocytes: Peripheral progeny includes mature CD4-D8-T cells bearing αβ TCR
44. + cell lines in response to TCR engagement
45. IL-4 expression at the onset of islet inflammation predicts nondestructive insulitis in nonobese diabetic mice
46. PCR assays for endogenous Ig gene rearrangement
47. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
48. Hybridization analysis of DNA blots
49. The T-cell repertoire is heavily influenced by tolerance to polymorphic, self-antigens
50. T-cell recognition of minor lymphocyte stimulating (Mls) gene products
51. IFN-γ gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice
52. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse
53. The CD69 receptor: A multipurpose cell-surface trigger for hematopoietic cells
54. The IL-2 receptor complex: Its structure, function, and target genes
55. a determinants
56. Tissue-specific expression of messenger RNAs encoding endogenous viral superantigens
57. Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice: The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes
58. g7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet β cells of nonobese diabetic mice
59. Antigen activation rescues recent thymic emigrants from programmed cell death in the BB rat
60. Promiscuous activation and cell cycle entry in T cells from autoimmune animals
61. The identification of a novel T cell activation state controlled by a diabetogenic gene
62. Regulatory T cells in autoimmunity
63. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance
64. + T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10
65. + immunoregulatory T cells that control autoimmune diabetes
66. + naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state
67. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production
68. Autoimmune disease as a consequence of developmental abnormality of a T cell population
69. Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct Vβ genes
70. The structural basis of T cell activation by superantigens
71. a mice: A role for the third complementarity-determining region (CDR3) of the T cell receptor in superantigen recognition
72. Induction of responsiveness in superantigen-induced anergic T cells: Role for ligand density and constimulatory signals
73. Genetic analysis of autoimmune type I diabetes mellitus in mice
74. Polygenic control of autoimmune diabetes in non-obese diabetic mice
75. Genetic control of autoimmunity in type I diabetes
76. Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus
77. Rubella infection and diabetes mellitus
78. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase
79. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice
80. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes
81. T cell cross-reactivity between coxsackievirus and glutamic acid decarboxylase is associated with a murine diabetes susceptibility allele
82. Acceleration of type I diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets
83. Superantigen-like effects and incidence of diabetes in NOD mice
84. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology
85. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes
86. Retroviral superantigens and type I diabetes mellitus
87. nod to the development of insulitis in non-obese diabetic mice
88. Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice
89. Major histocompatibility complex-linked control of autoimmunity
90. An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes
91. A mechanism for the major histocompatibitity complex-linked resistance to autoimmunity
92. Thymic and postthymic regulation of diabetogenic CD8 T cell development in TCR-transgenic nonobese diabetic mice
93. Effect of MHC transgene expression on spontaneous insulin autoantibody class switch in nonobese diabetic mice
94. H gene utilisation in the non-obese diabetic mouse
95. + B cells
96. + B cells in viable moth-eaten and normal mice
97. Requirement of dendritic cells and B cells in the clonal deletion of Mis Mls-reactive T cells in the thymus
98. Distinct mechanisms of neonatal tolerance induced by dendritic cells and thymic B cells